GSK3A and Alzheimer disease: Abnormal GSK-3α and GSK-3β activities have been associated with multiple diseases including diabetes, inflammation, cancer, bipolar disorder and neurodegenerative diseases including Parkinson’s disease (PD), Alzheimer’s disease (AD) and Huntington’s disease (HD)9–13.